NCT02747407View on ClinicalTrials.gov

Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

January 31, 2020

Study Completion Date

September 9, 2021

Conditions
AstrocytomaGliomaOligodendroglioma
Interventions
BIOLOGICAL

Hepatitis A Vaccine

OTHER

Laboratory Biomarker Analysis

Correlative studies

BIOLOGICAL

Tetanus Toxoid Vaccine

BIOLOGICAL

Trivalent Influenza Vaccine

Trial Locations (1)

27157

Comprehensive Cancer Center of Wake Forest University, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT02747407 - Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors | Biotech Hunter | Biotech Hunter